查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539366

动物分子诊断市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2033年

Veterinary Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球动物分子诊断市场的广泛研究报告，对关键市场动态进行了全面分析，包括驱动因素、新兴趋势、机会和挑战。本报告提供了对市场格局的全面了解，并帮助利害关係人做出明智的决策。

关键见解

  • 动物分子诊断市场规模（2024年）：2.147亿美元
  • 市场预测金额（2033年）：4.377亿美元
  • 全球市场成长率（2024-2033年年复合成长率）：8.2%

动物分子诊断市场 - 研究范围：

动物分子诊断市场包含一系列用于准确检测和分析动物疾病的先进诊断技术。这些技术包括聚合酶链反应（PCR）、次世代定序（NGS）和其他分子方法，为各种兽医疾病的诊断提供高灵敏度和特异性。分子诊断对于识别宠物和牲畜的病原体、遗传性疾病和其他健康问题非常重要，改善疾病管理和治疗结果。该市场的推动因素包括分子生物学的进步、人畜共通疾病的日益普及以及对快速、准确的诊断解决方案不断成长的需求。

推动市场成长的因素：

全球兽医分子诊断市场受到几个关键因素的推动，例如动物传染病患者病率的上升、宠物饲养量的增加以及动物健康意识的提高。分子诊断可提供准确、及时的结果，对于有效的疾病管理和预防非常重要。诊断技术的进步，例如兽医医疗基础设施的扩大和携带式且易于使用的诊断设备的开发，也促进了市场的成长。此外，分子诊断与远距医疗和数位健康解决方案的整合提高其可近性和采用率。

市场限制因素：

儘管成长前景广阔，但动物分子诊断市场仍面临挑战，例如高成本以及对与先进诊断技术相关的专业知识的需求。将分子诊断引进兽医实践所需的初始投资可能很大，特别是对于规模较小的实践。此外，人们也担心分子诊断测试的标准化和监管，这可能会影响其采用和可靠性。应对这些挑战需要不断进步的技术、具有成本效益的解决方案和明确的监管框架，以确保分子诊断的广泛接受和有效性。

市场机会：

由于技术创新和不断变化的兽医需求，兽医分子诊断市场提供了巨大的成长机会。新型诊断分析和平台的市场发展，以及对个人化兽医医学日益成长的兴趣，开闢新的市场扩张途径。对疾病早期检测和预防的需求不断成长，加上宠物人性化的趋势，预计将推动先进分子诊断的采用。策略合作伙伴关係、研发投资以及整合诊断解决方案的采用对于希望利用这些机会并推动市场成长的公司非常重要。

本报告中讨论的关键问题

  • 推动动物分子诊断市场全球成长的关键因素是什么？
  • 哪些应用和地区引领兽医分子诊断的采用？
  • 技术进步如何重塑兽医分子诊断市场的竞争格局？
  • 谁是动物分子诊断市场的主要参与者？ 他们采取什么策略来保持竞争力？
  • 全球动物分子诊断市场的新趋势和未来前景是什么？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含/排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 市场创新/发展趋势

第4章 关键成功因素

  • 主要促销策略：依製造商分类
  • 主要法规
  • PESTEL 分析
  • 波特的分析
  • 产品发布活动
  • 产品采用/使用分析
  • 产品 USP/特点
  • 产量分析：依地区
  • 偿付情境
  • 交易分析
  • 价值链分析

第5章 市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第6章 COVID-19 危机分析

  • 新冠肺炎（COVID-19）与影响分析
    • 依产品
    • 依疾病分类
    • 依种类
    • 依最终用户
    • 依国家/地区
  • 2024年市场情景

第7章 全球市场需求（金额或规模，百万美元）分析

  • 2019-2023年过去的市值（百万美元）分析
  • 2024-2033年当前和未来市场规模（百万美元）的分析和预测：依市场分类
    • 年成长趋势分析
    • 绝对数量机会分析

第8章 全球市场分析：依产品

  • 简介/主要发现
  • 2019-2023年历史市场规模（百万美元）分析：依产品
  • 2024-2033年当前和未来市场规模（百万美元）分析和预测：依产品
    • PCR试剂盒
    • INAAT 套件
    • 微阵列晶片套件
    • DNA定序试剂盒
  • 市场吸引力分析：依产品分类

第9章 全球市场分析：依疾病分类

  • 简介/主要发现
  • 2019-2023年历史市场规模（百万美元）分析：依疾病
  • 2024-2033年当前和未来市场规模（百万美元）分析和预测：依疾病
    • 无形体属
    • 埃利希氏体属
    • 新城疫
    • 流感
    • 猪繁殖与呼吸症候群（PRRS）
    • 其他
  • 市场吸引力分析：依疾病分类

第10章 世界市场分析：依类型

  • 简介/主要发现
  • 历史市场规模分析（百万美元）：依类型，2019-2023年
  • 2024-2033年当前和未来市场规模（百万美元）的分析和预测：依类型
    • 牲畜
    • 宠物
  • 市场吸引力分析：依类型

第11章 全球市场分析：依最终用户

  • 简介/主要发现
  • 2019-2023年历史市场规模分析（百万美元）：依最终用户
  • 2024-2033年当前和未来市场规模（百万美元）的分析和预测：依最终用户
    • 动物医院
    • 临床实验室
    • 兽医研究所
  • 市场吸引力分析：依最终用户分类

第12章 世界市场分析：依地区

  • 简介/主要发现
  • 2019-2023年历史市场规模（百万美元）分析：依地区
  • 目前与未来市场规模（百万美元）分析预测：依地区，2024-2033年
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东、非洲
  • 市场吸引力分析：依地区

第13章 北美市场分析

第14章 拉丁美洲市场分析

第15章 欧洲市场分析

第16章 东亚市场分析

第17章 南亚市场分析

第18章 大洋洲市场分析

第19章 中东与非洲（MEA）市场分析

第20章 市场结构分析

  • 市场分析：依公司层级
  • 主要公司市占率分析
  • 市场现况分析

第21章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详情
    • bioMerieux SA
    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen NV
    • Neogen Corporation
    • ID. Vet
    • INDICAL BIOSCIENCE GmbH
    • Veterinary Molecular Diagnostics, Inc.

第22章 使用的先决条件与缩写

第23章 研究方法

简介目录
Product Code: PMRREP12874

Persistence Market Research has recently published an extensive report on the global Veterinary Molecular Diagnostics market, providing a thorough analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a comprehensive understanding of the market landscape, helping stakeholders make informed decisions.

Key Insights:

  • Veterinary Molecular Diagnostics Market Size (2024E): USD 214.7 Mn
  • Projected Market Value (2033F): USD 437.7 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 8.2%

Veterinary Molecular Diagnostics Market - Report Scope:

The Veterinary Molecular Diagnostics market encompasses a range of advanced diagnostic technologies used for the precise detection and analysis of diseases in animals. These technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and other molecular methods that offer high sensitivity and specificity for diagnosing various veterinary conditions. Molecular diagnostics are crucial for identifying pathogens, genetic disorders, and other health issues in pets and livestock, leading to improved disease management and treatment outcomes. The market is driven by advancements in molecular biology, the increasing prevalence of zoonotic diseases, and the growing demand for rapid and accurate diagnostic solutions.

Market Growth Drivers:

The global Veterinary Molecular Diagnostics market is propelled by several key factors, including the rising incidence of infectious diseases in animals, increased pet ownership, and growing awareness about animal health. Molecular diagnostics offer precise and timely results, which are essential for effective disease management and prevention. The expansion of veterinary healthcare infrastructure and advancements in diagnostic technologies, such as the development of portable and user-friendly diagnostic devices, are also contributing to the market's growth. Additionally, the integration of molecular diagnostics with telemedicine and digital health solutions is enhancing their accessibility and adoption.

Market Restraints:

Despite its promising growth, the Veterinary Molecular Diagnostics market faces challenges such as high costs associated with advanced diagnostic technologies and the need for specialized expertise. The initial investment required for implementing molecular diagnostics in veterinary practices can be significant, especially for smaller clinics. Additionally, there are concerns related to the standardization and regulation of molecular diagnostic tests, which can impact their adoption and reliability. Addressing these challenges requires ongoing advancements in technology, cost-effective solutions, and clear regulatory frameworks to ensure the broad acceptance and effectiveness of molecular diagnostics in veterinary care.

Market Opportunities:

The Veterinary Molecular Diagnostics market presents significant growth opportunities driven by technological innovations and evolving veterinary needs. The development of novel diagnostic assays and platforms, along with the increasing focus on personalized veterinary care, is opening new avenues for market expansion. The rising demand for early disease detection and prevention, coupled with the growing trend of pet humanization, is expected to drive the adoption of advanced molecular diagnostics. Strategic partnerships, investments in R&D, and the introduction of integrated diagnostic solutions will be crucial for companies looking to capitalize on these opportunities and drive market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Veterinary Molecular Diagnostics market globally?
  • Which applications and regions are leading the adoption of Veterinary Molecular Diagnostics?
  • How are technological advancements reshaping the competitive landscape of the Veterinary Molecular Diagnostics market?
  • Who are the key players in the Veterinary Molecular Diagnostics market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Veterinary Molecular Diagnostics market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Veterinary Molecular Diagnostics market, such as IDEXX Laboratories, Neogen Corporation, and Zoetis, are focusing on innovation, technological advancements, and strategic collaborations to maintain a competitive edge. These companies are investing heavily in R&D to develop cutting-edge diagnostic solutions that improve animal health and streamline veterinary practices. Partnerships with research institutions, technology providers, and healthcare organizations are essential for expanding market reach and enhancing diagnostic capabilities. Emphasizing accuracy, cost-effectiveness, and comprehensive diagnostic solutions are key strategies for sustaining leadership in the rapidly evolving Veterinary Molecular Diagnostics market.

Key Companies Profiled:

  • bioMerieux SA
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Neogen Corporation
  • ID. Vet
  • INDICAL BIOSCIENCE GmbH
  • Veterinary Molecular Diagnostics, Inc.

Key Segments Covered in Veterinary molecular diagnostics Industry Research

Product

  • PCR Kits
  • INAAT Kits
  • Microarray Kits
  • DNA Sequencing Kits

Disease

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)

Species

  • Livestock Animals
  • Companion Animals

End User

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies, by Manufacturers
  • 4.2. Key Regulations
  • 4.3. PESTEL Analysis
  • 4.4. Porter's Analysis
  • 4.5. Product Launch Activities
  • 4.6. Product Adoption/Usage Analysis
  • 4.7. Product USPs/ Features
  • 4.8. Production Analysis by Region
  • 4.9. Reimbursement Scenario
  • 4.10. Trade Analysis
  • 4.11. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Veterinary Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Strategic Collaborations Among Key Players
    • 5.2.2. Rise in Awareness About Diseases in Animals Worldwide
    • 5.2.3. High Adoption of Molecular Diagnostic Kits for Veterinary Diseases
    • 5.2.4. Higher Prevalence of Chronic & Infectious Diseases in Animals
    • 5.2.5. Advancements in Molecular Technology
    • 5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
    • 5.2.7. Ease in FDA Clearance for Veterinary Products
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Disease
    • 6.1.3. By Species
    • 6.1.4. By End User
    • 6.1.5. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2024-2033
    • 8.3.1. PCR Kits
      • 8.3.1.1. RT-PCR Kits
      • 8.3.1.2. RAPD-PCR Kits
    • 8.3.2. INAAT Kits
    • 8.3.3. Microarray Kits
    • 8.3.4. DNA Sequencing Kits
  • 8.4. Market Attractiveness Analysis by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
    • 9.3.1. Anaplasma spp.
    • 9.3.2. Ehrlichia spp.
    • 9.3.3. New Castle Disease
    • 9.3.4. Influenza
    • 9.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
    • 9.3.6. Others
  • 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Species

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis by Species, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Species, 2024-2033
    • 10.3.1. Livestock Animals
      • 10.3.1.1. Porcine
      • 10.3.1.2. Poultry
      • 10.3.1.3. Bovine/Cattle
      • 10.3.1.4. Aquatic
      • 10.3.1.5. Ovine
    • 10.3.2. Companion Animals
      • 10.3.2.1. Canine
      • 10.3.2.2. Feline
      • 10.3.2.3. Avian
  • 10.4. Market Attractiveness Analysis by Species

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
    • 11.3.1. Veterinary Hospitals
    • 11.3.2. Clinical Laboratories
    • 11.3.3. Veterinary Research Institutes
  • 11.4. Market Attractiveness Analysis by End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East & Africa
  • 12.4. Market Attractiveness Analysis by Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Disease
    • 13.3.4. By Species
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Disease
    • 13.4.4. By Species
    • 13.4.5. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Disease
        • 13.8.1.2.3. By Species
        • 13.8.1.2.4. By End User
    • 13.8.2. Canada Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Disease
        • 13.8.2.2.3. By Species
        • 13.8.2.2.4. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By Disease
    • 14.3.4. By Species
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Disease
    • 14.4.4. By Species
    • 14.4.5. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Disease
        • 14.8.1.2.3. By Species
        • 14.8.1.2.4. By End User
    • 14.8.2. Brazil Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Disease
        • 14.8.2.2.3. By Species
        • 14.8.2.2.4. By End User
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Disease
        • 14.8.3.2.3. By Species
        • 14.8.3.2.4. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Disease
    • 15.3.4. By Species
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Disease
    • 15.4.4. By Species
    • 15.4.5. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Disease
        • 15.8.1.2.3. By Species
        • 15.8.1.2.4. By End User
    • 15.8.2. Italy Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Disease
        • 15.8.2.2.3. By Species
        • 15.8.2.2.4. By End User
    • 15.8.3. France Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Disease
        • 15.8.3.2.3. By Species
        • 15.8.3.2.4. By End User
    • 15.8.4. U.K. Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Disease
        • 15.8.4.2.3. By Species
        • 15.8.4.2.4. By End User
    • 15.8.5. Spain Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Disease
        • 15.8.5.2.3. By Species
        • 15.8.5.2.4. By End User
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Disease
        • 15.8.6.2.3. By Species
        • 15.8.6.2.4. By End User
    • 15.8.7. Russia Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Disease
        • 15.8.7.2.3. By Species
        • 15.8.7.2.4. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Disease
    • 16.3.4. By Species
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Disease
    • 16.4.4. By Species
    • 16.4.5. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Disease
        • 16.8.1.2.3. By Species
        • 16.8.1.2.4. By End User
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Disease
        • 16.8.2.2.3. By Species
        • 16.8.2.2.4. By End User
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Disease
        • 16.8.3.2.3. By Species
        • 16.8.3.2.4. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Disease
    • 17.3.4. By Species
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Disease
    • 17.4.4. By Species
    • 17.4.5. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Disease
        • 17.8.1.2.3. By Species
        • 17.8.1.2.4. By End User
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Disease
        • 17.8.2.2.3. By Species
        • 17.8.2.2.4. By End User
    • 17.8.3. Malaysia Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Disease
        • 17.8.3.2.3. By Species
        • 17.8.3.2.4. By End User
    • 17.8.4. Thailand Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Disease
        • 17.8.4.2.3. By Species
        • 17.8.4.2.4. By End User

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Disease
    • 18.3.4. By Species
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Disease
    • 18.4.4. By Species
    • 18.4.5. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Disease
        • 18.8.1.2.3. By Species
        • 18.8.1.2.4. By End User
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Disease
        • 18.8.2.2.3. By Species
        • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. North Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Disease
    • 19.3.4. By Species
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Disease
    • 19.4.4. By Species
    • 19.4.5. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Disease
        • 19.8.1.2.3. By Species
        • 19.8.1.2.4. By End User
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Disease
        • 19.8.2.2.3. By Species
        • 19.8.2.2.4. By End User
    • 19.8.3. South Africa Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By Disease
        • 19.8.3.2.3. By Species
        • 19.8.3.2.4. By End User
    • 19.8.4. North Africa Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By Disease
        • 19.8.4.2.3. By Species
        • 19.8.4.2.4. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. bioMerieux SA
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Sales Footprint
      • 21.3.1.4. Key Financials
      • 21.3.1.5. SWOT Analysis
      • 21.3.1.6. Key Developments
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. IDEXX Laboratories, Inc.
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Sales Footprint
      • 21.3.2.4. Key Financials
      • 21.3.2.5. SWOT Analysis
      • 21.3.2.6. Key Developments
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Thermo Fisher Scientific Inc.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Sales Footprint
      • 21.3.3.4. Key Financials
      • 21.3.3.5. SWOT Analysis
      • 21.3.3.6. Key Developments
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. Qiagen N.V.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Sales Footprint
      • 21.3.4.4. Key Financials
      • 21.3.4.5. SWOT Analysis
      • 21.3.4.6. Key Developments
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Neogen Corporation
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Sales Footprint
      • 21.3.5.4. Key Financials
      • 21.3.5.5. SWOT Analysis
      • 21.3.5.6. Key Developments
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. ID. Vet
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Sales Footprint
      • 21.3.6.4. Key Financials
      • 21.3.6.5. SWOT Analysis
      • 21.3.6.6. Key Developments
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. INDICAL BIOSCIENCE GmbH
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Sales Footprint
      • 21.3.7.4. Key Financials
      • 21.3.7.5. SWOT Analysis
      • 21.3.7.6. Key Developments
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. Veterinary Molecular Diagnostics, Inc.
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Sales Footprint
      • 21.3.8.4. Key Financials
      • 21.3.8.5. SWOT Analysis
      • 21.3.8.6. Key Developments
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology